Category: Clinical Insights

69 posts found

MDMA Gains Steam for PTSD Treatment

Phase 3 studies are underway, and current research sees potential for MDMA in psychotherapy.

A recent meta-analysis of over 100 trials and studies found lavender to significantly reduce anxiety levels.

According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

PwC explores how social factors impact chronic health conditions.

The utilization of opioids, compounds, and physician-dispensed medications have significantly decreased.

Looking at over 29 billion private health claims, this study found that claim lines related to telehealth rose 624% from 2014-2018.

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.

Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.

The workforce is aging, getting younger, and gaining more women, all at once. What does that mean for claims management?

Despite having little clinical impact, topical creams continue to be utilized widely in workers’ comp.

Prescribing has doubled since 2003, overdose deaths quadrupled since 1996, and misuse accounts for 20% of benzodiazepine use.

An analysis of 90,000 private claims explores the relationship between early PT and reduced long-term opioid use in musculoskeletal pain.

The American Gastroenterological Association released guidance on properly prescribing medications for OIC.

Prev 1 2 3 4 5 Next